Women and Infants Participating in National Study of New Fertility Drug
Monday, December 13, 2010
Women & Infants Hospital is one of the centers participating in a national, randomized study to investigate the efficacy of a new fertility drug. This new drug would require one weekly injection rather than daily injections to simulate ovaries to make follicles. Women between the ages of 35 and 42 may qualify for an in vitro fertilization (IVF) cycle at no cost with the investigational drug.
Improved quality of life for patients
Lead investigator is Bala Bhagavath, MD, a reproductive endocrinologist in the Center for Reproduction and Infertility at Women & Infants Hospital and assistant professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University.
“Traditional infertility treatment requires the use of a drug that is administered through daily injections to stimulate the ovaries to produce eggs,” said Dr. Bhagavath. “This new drug would require a single injection that lasts seven days. This is obviously much easier for the patient, and we’re hoping it will be equally, if not more, effective than the current drugs available. ”
Patients are now being enrolled at the hospital’s Center for Reproduction and Infertility in Providence, Boston and nine other locations. For information, call Patty Pursue at the Center for Reproduction and Infertility at 453-7500, extension 8404, or visit womenandinfants.org/infertility.